Muscle Inflammation Unknown Status Phase 2 / 3 Trials for Belimumab (DB08879)

Also known as: Inflammation; Muscle / Myositis / Myositis unspecified (disorder) / Inflammatory disorder of muscle (disorder) / Inflammatory myopathy NOS / Myositis (disorder) / Myalgia &/or myositis: [NOS] / Myositis, unspecified

IndicationStatusPhase
DBCOND0042362 (Muscle Inflammation)Unknown Status2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02347891Belimumab in Idiopathic Inflammatory MyositisTreatment